Abstract: With the rapid development of Internet technology, platform economy has become one of the most promising business models, which builds online platforms through the Internet and mobile technology to connect supply and demand, forming a multi-sided market to achieve resource integration and transactions. In this context, the pharmaceutical industry is not an exception, facing new opportunities and challenges. The pharmaceutical distribution enterprises in China have the characteristics of industry over-concentration, which means that a few enterprises hold the majority of market share, leading to a lack of competition and innovation. However, with the promotion of national medical system policy, the pharmaceutical distribution industry is accelerating its restructuring and transforming into cross-regional and cross-industry comprehensive distribution enterprises. Therefore, pharmaceutical distribution enterprises need to re-examine their business models and innovate. This article takes Jiuzhou Tong Medicine Group Co., Ltd. (hereinafter referred to as Jiuzhou Tong) as an example to study and analyze its business model evolution. As a well-known enterprise in the pharmaceutical distribution field, Jiuzhou Tong was established in 2000 and began to grow. With the continuous deepening of national medical system reform, Jiuzhou Tong gradually improved its business development model and made breakthroughs in the process of platformization, digitization, and Internetization. In 2018, Jiuzhou Tong completed its business model evolution, further consolidating its position in the Chinese pharmaceutical industry. The business model evolution process of Jiuzhou Tong has high representativeness and enlightenment significance. This article first uses the literature review method to sort out and summarize the relevant literature on platform economy and business model evolution, analyze the connection and difference between Jiuzhou Tong's business model evolution and existing research, and future development trends. Secondly, using the case analysis method, through in-depth investigation and analysis of Jiuzhou Tong's case, explore its business model evolution process under the platform economy, understand the reasons and experience of its success, and draw conclusions and inspiration to realize the synergy and optimization of the pharmaceutical industry chain through the Internet platform, and achieve the upgrading and transformation of the pharmaceutical industry. This article aims to analyze the application and impact of the platform economy model in the pharmaceutical industry, and provide reference for the research of platform economy. Keywords: platform economy, business model, Jiuzhou Tong Medicine Group.

摘要: 随着互联网技术的快速发展平台经济已成为当前最具发展前景的商业模式之一它通过互联网和移动技术构建在线平台将供需双方连接起来从而形成一个多边市场实现资源整合和交易。在这种情况下医药行业也不例外面临着新的机遇和挑战。中国的医药流通企业具有行业过度集中的特点这意味着少数企业掌握了大部分市场份额导致缺乏竞争和创新。然而随着国家医疗体制政策的推动医药流通行业正加速重塑其格局并向跨区域性和跨行业性的综合

原文地址: https://www.cveoy.top/t/topic/bYZw 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录